Microsoft billionaire Bill Gates is set to stand trial in the Netherlands for allegedly misleading the public about the ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung ...

According to an infectious disease expert, Hong Kong’s flu season is expected to start in December; it is likely to have two ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Moderna shares rebound after six days of losses. Analysts mixed on stock with Strong Sell rating but potential for future growth.

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Montréal and UK-based startup Epitopea has raised $31 million USD ($43 million CAD) in what it called pre-Series A funding ...

The CDC is moving toward a risk-based strategy, allowing patient input as to the frequency of COVID-19 vaccine boosters.

The science behind vaccines is based on the fundamental principle of training the immune system to recognize and fight ...

On BNTX's third-quarter 2024 earnings call, investors' focus is likely to be on the updates related to its oncology pipeline.

A new framework bridges a gap in understanding RNA therapeutics by linking the structure of lipid nanoparticles to immune ...